Socially based discrimination against clinically appropriate care

Other OA: closed
⚙ AI-generated summary by qwen3.7-flash+body, 2026-11-12 ⓘ

This commentary critiques Ontario’s delisting of IVF funding as discriminatory against women with endometriosis and other indications, arguing that the policy violates human rights principles by excluding socially disadvantaged Canadians from clinically appropriate infertility care.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-12 · read from full text ⓘ

This editorial critiques the lack of public funding for in vitro fertilization in Canada, arguing that such policies discriminate against socially disadvantaged individuals seeking clinically appropriate infertility treatments. The author highlights that conditions including endometriosis, oocyte depletion, and tubal scarring were historically excluded from coverage, forcing patients into expensive private options or leaving them without care. The text posits that denying access to IVF violates human rights principles by creating a two-tiered medical system based on socioeconomic status rather than clinical need. Relevance to endometriosis: listed as one indication for IVF, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 5,746 characters · extracted from oa-pdf · click to expand
T he Human Rights Challenge filed Aug. 18 in Ontario by Amir Attaran with Anna Ilha brought national attention to discrimination against socially disadvantaged Canadian women/couples who are seeking clini- cally appropriate care. Ontario publicly funded in vitro fer- tilization (IVF) from 1985 to April Fool’s Day 1994, 1 when it was “delisted” except for completely blocked fallopian tubes. This delisting, foolish from a sci- entific, clinical, social, ethical and even economic perspective, 1-4 excluded most Canadians with clinically appropriate indications for IVF from having chil- dren, including those with oocyte deple- tion (common in cancer survivors and women over 35), scarred fallopian tubes, endometriosis and inadequate sperm. These Canadians were also generally excluded from being chosen by an adopting-out birth mother (many of whom may want a white picket fence) 3 and from international adoption (expen- sive). With Ontario delisting IVF, other provinces did not go forward with fund- ing IVF. Ten years after Ontario delisted IVF, Canada’s Act Respecting Assisted Human Reproduction and Related Researc h became law. Although this act is similar to legislation in Australia, Western Europe and other countries in promoting the safety of women undergoing assisted reproduction and health of children born thereof, Canada is alone in not funding IVF. 3 Indeed, only 15% of Canadian women with clinical indications access IVF compared with countries that fund IVF. 5 This Canadian policy may be dis- criminatory in light of Section 2(E) of our Act which states, “persons who seek to undergo assisted human reproduction pro- cedures must not be discriminated against … including on the basis of sexual orien- tation or marital status.” 3 The act’s use of the word “including” suggests other social factors are also not appropriate bases for discrimination. 3 Ontario’s 1994 delisting of IVF was based on misinterpretation of the Royal Commission on Reproductive Technolo- gies’ 1993 recommendation to “proceed with care,” as well as a lack of understand- ing of the financial repercussions of refus- ing to fund IVF and insensitivity to the experience of the many Canadians who want to be a parent. The lack of under- standing that allowed Ontario to “pro- ceed” only for its wealthier citizens, and not to “care” for its socially less advan- taged citizens continues as reflected in comments posted on the Globe and Mail’s online discussion board the day following its coverage of the Attaran human rights challenge, including: blaming women “over the age of 28” for delaying having children (when social factors may force women and men to delay), and worrying that we would have to “pay a lot more in taxes” (when, in fact, public funding of IVF would benefit provincial coffers 1,3,4). IVF, especially with single embryo transfer, prevents the high-order multiple pregnancies that result when women, financially excluded from accessing IVF, “choose” gonadotrophin fertility drugs. These high-order multiple pregnancies are associated with extreme premature birth and huge costs of neonatal intensive care and long-term support of surviving children with cerebral palsy, blindness, and cognitive and other impairments. 1,3,4 These costs were recognized in Quebec’s recent decision to publicly fund IVF, and in the Aug. 26, 2009 release of the Ontario Expert Panel on Infertility and Adoption Report. According to clinician and researcher Ed Hughes, the reasons why IVF has remained unfunded for so long in Canada, are that “sub-fertile Canadians are largely invisible” and “poorly under- stood,” and the medical profession has not lobbied for IVF funding, as noted in the Nova Scotia Supreme Court decision against public funding of IVF. 4 The success of Terry Buffett’s 2006 human rights challenge, resulting in the Canadian Armed Forces paying for his wife’s IVF cycles and amending its pol- icy regarding IVF funding, suggests clini- cally appropriate care may indeed be a human right in Canada. If the Attaran human rights challenge is successful, all provinces may not only be forced to end their discrimination against socially disad- vantaged Canadians who want clinically appropriate infertility treatment, but also to stop the creeping discrimination of two-tiered medicine, including access to more expensive, but more effective new clinical strategies. Jeff Nisker MD PhD Professor of Obstetrics and Gynaecology and Oncology Schulich School of Medicine and Dentistry The University of Western Ontario London, Ont. REFERENCES 1. Nisker JA. Anniversary of injustice: April fool's day, 1994. Will the enactment of Bill C-6 be the birthday of equitable reproductive health care in Canada. J Obstet Gynaecol Can2004;26:321-4. 2. Hughes EG, Beecroft ML, Wilkie V, et al. A multi- centre randomized controlled trial of expectant man- agement versus IVF in women with Fallopian tube patency. Hum Reprod2004;19:1105-9. 3. Nisker J. Distributive justice and infertility treatment in Canada.J Obstet Gynaecol Can2008;30: 425-31. 4. Hughes E. Access to effective fertility care in Canada. J Obstet Gynaecol Can2008;30: 389-93. 5. Collins J. An international survey of the health eco- nomics of IVF and ICSI. Hum Reprod Update 2002;8:265-77. Salon CMAJ All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Can adian Medical Association. CMAJ  NOVEMBER 10, 2009  181(10) © 2009 Canadian Medical Association or its licensors 764 DOI:10.1503/cmaj.091620 Cynthia O’Brien’s clay sculpture, “Emer- gence One” (2009), represents a sperm. Cynthia O’Brien Socially based discrimination against clinically appropriate care A longer version of this article was published at cmaj.ca

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

MeSH descriptors

Delivery of Health Care Fertilization in Vitro Prejudice Canada Delivery of Health Care Female Fertilization in Vitro Government Regulation Humans Patient Rights Reproductive Techniques, Assisted Reproductive Techniques, Assisted Social Class Stereotyping

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-15T09:34:25.365398+00:00
pubmed
last seen: 2026-10-08T21:06:50.232585+00:00
unpaywall
last seen: 2026-11-19T08:49:44.633026+00:00